Because the market remains convinced that the next down phase of the memory cycle will eventually hit, Micron's stock is ...

Viking Therapeutics raised $575 million to fund major obesity drug trials, develop its pipeline, and support commercial ...

Net interest margins are positioned for structural recovery as the interest rate environment turns and higher-yielding assets ...

Micron and other memory makers are well aware of the cyclical risk in the industry, and as such have been signing long-term ...

Anyone who has invested in the artificial intelligence (AI) space for a while knows how good of an AI investment Taiwan ...

But Microsoft ( MSFT -1.93%) is bucking the downward trend. Its shares have gained around 8% over the past month on optimism ...

Deep contingency reserves and clean asset quality give the bank a cushion to weather economic shocks while pursuing growth.

Cost savings are accelerating ahead of schedule, creating operating leverage without major upfront investment.

ServiceNow has pulled further ahead over the past two years, but Workday's growth remains steady — here's what the diverging ...

Coca-Cola ( KO +2.06%) shares pay a dividend yield of 2.3%. Nike ( NKE -0.03%) stock pays a dividend yield of 4.4%. Here's ...

Green Thumb's biggest near-term catalyst remains federal policy, but its investment case shouldn't depend entirely on ...

BioNTech announced that it was stopping a Phase 2 clinical trial for autogene cevumeran, which it was testing as an adjuvant ...